News & Analysis as of

Physicians China

Benesch

The “China Initiative” Just Won’t Die - Recent DOJ Settlement Highlights the Lasting Effect of Trump-Era Policy on Health Care...

Benesch on

In 2022, the United States Department of Justice (“DOJ”) announced its decision to shut down the “China Initiative”—the controversial program used to investigate and prosecute academics, health care workers, and...more

Health Care Compliance Association (HCCA)

FBI: More Awareness, Due Diligence Needed To Fight China in New ‘Space Race’ for Data

Report on Patient Privacy 21, no. 10 (October, 2021) - Conducting a risk analysis is a basic tenet of security compliance, with the overarching goal of understanding where protected health information (PHI) “lives” in an...more

Harris Beach PLLC

Proposed Legislation Seeks to Reinforce Healthcare Workforce During COVID-19 Emergency

Harris Beach PLLC on

In an effort to combat the COVID-19 pandemic and tap into available healthcare workers from around the world, on May 5, 2020 a group of six senators introduced bipartisan legislation which seeks to enhance the healthcare...more

Seyfarth Shaw LLP

Recent Trends in Telemedicine in China

Seyfarth Shaw LLP on

The COVID-19 outbreak inevitability has spurred unprecedented progress on a paradigm shift to telemedicine. According to a recent study by the Boston Consulting Group, China is already the world’s third largest Med Tech...more

Robins Kaplan LLP

Financial Daily Dose 1.24.2020 | Top Story: OCC Hits Former Wells Fargo Execs With Enforcement Actions Over Sham-account Scandal

Robins Kaplan LLP on

The OCC announced yesterday that it’s bringing enforcement actions against five former Wells Fargo bank executives as part of their alleged roles in the bank’s sales practices scandal. The agency further revealed that it’s...more

Morgan Lewis

Physician Speaking Fees Remain Focus of Commercial Bribery Regulation in China

Morgan Lewis on

The Administration for Market Regulation of Jing’an District in Shanghai (AMR) on May 7 announced an administrative penalty decision against the Shanghai branch of a multinational pharmaceutical company (the Branch) for...more

Hogan Lovells

China’s new rules on telemedicine and Internet hospitals - some things clarified, some questions left unanswered

Hogan Lovells on

China's new rules for Internet-based medical services – telemedicine, Internet hospitals and Internet-based diagnosis came into force on 17 July 2018. ...more

Morgan Lewis

Shanghai Regulator: Speaking Fees to Physicians Constitute Bribery

Morgan Lewis on

A local regulator in Shanghai has recently fined a domestic medical device company for commercial bribery after determining that the company had unduly influenced a group of seven physicians when it paid them speaking fees to...more

Thomas Fox - Compliance Evangelist

Put the Candle Back: the AstraZeneca FCPA Enforcement Action

I am back from a two-week summer study program at Oxford, run by Michigan State University through its Odyssey to Oxford program. It was a great experience. My class was on The Tudors in film and print so not only did I...more

The Volkov Law Group

Lessons Learned from AstraZeneca’s $5.5 Million SEC FCPA Settlement

The Volkov Law Group on

Last week, the SEC added another pharmaceutical company to its list of FCPA violators when AstraZeneca agreed to a $5.5 million settlement with the SEC. AZ is now the 25th drug or medical device company to pay an FCPA penalty...more

Foley & Lardner LLP

The Telehealth Top 10 for 2015

Foley & Lardner LLP on

Telehealth continues to be an innovative alternative to traditional brick-and-mortar medicine. The number of providers offering telehealth services is rapidly increasing and states are enacting laws requiring health plans to...more

The Volkov Law Group

Mead Johnson: Baby Formula and Bribes

The Volkov Law Group on

Last week, the SEC announced a settlement of an FCPA enforcement action for $12 million against Mead Johnson Nutrition for payment of bribes in China to health care professionals at state-owned hospitals. Mead Johnson’s...more

McDermott Will & Emery

Chinese Government Further Encourages, Regulates Multi-Site Practice by Physicians

McDermott Will & Emery on

The Opinions on Encouragement and Regulation of Multi-Sited Practices of Physicians demonstrate the Chinese government’s continued efforts to develop Chinese physicians’ ability to practise at multiple sites, and will provide...more

Blank Rome LLP

Court Decisions in the U.S. and China Bolster Law Enforcement’s Ability to Prosecute Global Corporate Corruption

Blank Rome LLP on

On October 6, 2014, the United States Supreme Court declined to accept an appeal involving violations of the Foreign Corrupt Practices Act (“FCPA”)—the U.S. statute that criminalizes the bribing of foreign officials. The...more

Fenwick & West LLP

Securities Litigation Alert: GlaxoSmithKline and Five Executives Convicted of Bribery in China

Fenwick & West LLP on

On Friday, September 19, 2014, a Chinese court found pharmaceutical giant GlaxoSmithKline guilty of bribing doctors and hospitals in order to increase sales of the company’s products in China. Among other things, the company...more

Thomas Fox - Compliance Evangelist

Lessons from GSK in China – Internal Controls, Auditing and Monitoring

One of the questions that GSK will have to face during the next few years of bribery and corruption investigations is how an allegedly massive bribery and corruption scheme occurred in its Chinese operations? The numbers went...more

16 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide